MiTF renal cell carcinoma can masquerade as other subtypes and may not respond as well to front-line therapies.
Demsky joined the University of Michigan Rogel Cancer Center communications team in 2019. Prior to that he served as director of communications for the University of Michigan's Life Sciences Institute and science editor for Medicine at Michigan Magazine. Contact: firstname.lastname@example.org
Study findings support the recent FDA approval of the immunotherapy agent for patients whose cancers have high number of mutations.
Scientists have long sought to target the interaction between the proteins p53 and Mdm2 in tumor cells, but their interaction in immune cells may be just as important.
Breast cancer stem cells from patients with different racial and ethnic backgrounds showed important differences in activation of immune response-related genes in mouse models.
Studies suggest the gut microbiome can influence immunotherapy side effects. Butyrate emerges as an intriguing candidate against inflammation in the colon.
Researchers Identify a New, Vital Player in Graft-Versus-Host Disease and Organ Transplant Rejection
How one long noncoding RNA could help improve outcomes in bone marrow and solid organ transplantation.